A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy	Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, acute myeloid leukemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, myeloid leukemia, neoplasm	Active, not recruiting	Phase 1	2025-09-26		NCT05104775

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Sichuan Baili Pharmaceutical Co., Ltd.	135
SystImmune Inc.	24

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Guizhou Medical University	Guiyang	China	8
Guangzhou First People's Hospital	Guangzhou	China	7
Ruijin Hospital, Shanghai Jiaotong University School of Medicine	Shanghai	China	45
Shengjing Hospital of China Medical University	Shenyang	China	32
The Fourth Hospital of Hebei Medical University	Shijiazhuang	China	33
The Second People's Hospital of Yibin	Yibin	China	1
Union Hospital Tongji Medical College Huazhong University Of Science And Technology	Wuhan	China	18